Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Howard Urnovitz
AddedFeb 19, 2024
UpdatedMay 31, 2026
Howard Urnovitz

Howard Urnovitz

Founder, Calypte Biomedical

CrunchbaseLinkedIn

Howard Urnovitz's Career

Calypte Biomedical
Calypte Biomedical

Portland, OR, US

Founder
FBB Biomed
FBB Biomed

Coralville, IA, US

CEO· C-Suite · Management

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Howard Urnovitz's Career

Calypte Biomedical
Calypte Biomedical
Public91988Portland, OR, US
Founder

Leadership at Calypte Biomedical

Adel KarasAdel KarasBoard Member
Roger GaleRoger GaleBoard Member

Similar to Calypte Biomedical

Bluejay DiagnosticsBluejay DiagnosticsActon, MA, USMedical Testsest. 2015Bluejay DiagnosticsActon, MA, US · est. 2015

Bluejay Diagnostics: Developing and marketing easy-to-use, affordable, non-invasive medical diagnostic tests.

Public · $8M19
OraSure TechnologiesOraSure TechnologiesBethlehem, PA, USDiagnostics, Medical Devicesest. 1987OraSure TechnologiesBethlehem, PA, US · est. 1987

OraSure Technologies, Inc. develops and markets diagnostic products and medical devices for HIV and drug testing.

Public · $136M840
American Bio MedicaAmerican Bio MedicaKinderhook, NY, USDrug Testsest. 1986American Bio MedicaKinderhook, NY, US · est. 1986

American Bio Medica Corp. develops and markets biomedical tech, including rapid drug screen tests.

Public100
Talis BiomedicalTalis BiomedicalMenlo Park, CA, USDiagnostic Testsest. 2010Talis BiomedicalMenlo Park, CA, US · est. 2010

Talis develops innovative diagnostic platforms for rapid, complex testing in diverse healthcare settings.

Public · $8.6M102
FBB Biomed
FBB Biomed
Seed$673.5k32019Coralville, IA, US
CEO· C-Suite · Management

Leadership at FBB Biomed

Julien ReyJulien ReyFounder

Similar to FBB Biomed

FloBioFloBioPhiladelphia, PA, USBlood Diagnosticsest. 2017FloBioPhiladelphia, PA, US · est. 2017

FloBio: Real-time blood analysis for point-of-care diagnostics, assessing bleeding risk since 2017.

Angel · $256k8
Liquid BiotechLiquid BiotechPhiladelphia, PA, USBlood Testsest. 2012Liquid BiotechPhiladelphia, PA, US · est. 2012

Liquid Biotech USA: Developing non-invasive blood tests for a healthier future.

Seed · $2M6
Banyan BiomarkersBanyan BiomarkersAlachua, FL, USDiagnostic Productsest. 2002Banyan BiomarkersAlachua, FL, US · est. 2002

Banyan Biomarkers: Pioneering vitro diagnostic products for traumatic brain injury detection.

Series A · $16.8M30
FYR DiagnosticsFYR DiagnosticsMissoula, MT, USBiotech, Diagnosticsest. 2016FYR DiagnosticsMissoula, MT, US · est. 2016

FYR Diagnostics: Pioneering biomarker detection tech for human health and agriculture since 2016.

Angel · $3M16

People Similar to Howard Urnovitz

Achmad ZakyAchmad ZakyCo-Founder · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakWillix HalimWillix HalimCEO · BukalapakBo ZhangBo ZhangCo-Founder · DiDiWILL WEI CHENGWILL WEI CHENGCo-Founder · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniFounder · Reliance RetailBrian KimBrian KimCo-Founder · KakaoKim Beom-sooKim Beom-sooCo-Founder · KakaoDaniel HendersonDaniel HendersonCo-Founder · PaxVaxDoug LevinsonDoug LevinsonCo-Founder & CEO · Fount BioMaxim MikheevMaxim MikheevFounder & CEO · BiomedicanChris HolmesChris HolmesCEO · FB FinancialDavid McDowellDavid McDowellFounder · GANEdward H SchaeferEdward H SchaeferBoard Member · Ffbw